Skip to content

Implementation of a strategy of osteoporosis screening in patients over 50 years of age with a first fracture, with intensive treatment and follow-up by a nurse-practitioner to prevent recurrent fractures in those patients with diagnosed osteoporosis

Implementation of a strategy of osteoporosis screening in patients over 50 years of age with a first fracture, with intensive treatment and follow-up by a nurse-practitioner to prevent recurrent fractures in those patients with diagnosed osteoporosis - Implementation of osteoporosis screening

Status
Recruiting
Phases
Phase 4
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON31623
Enrollment
1650
Registered
2007-07-18
Start date
2007-10-01
Completion date
Unknown
Last updated
2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

compliance and medication adherence osteoporosis and decreased bone mineral density

Interventions

None listed

Sponsors

Vrije Universiteit Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: population 1: -All patients 50 years of age or older, who have a clinical fracture and a low BMD defined as a T score * 2 population 2: -All patients 50 years of age or older, who have a clinical fracture and a BMD defined as a T score of * -1 and >-2 population 3: -All patients of 50 years or older, who have a clinical fracture and ar already being treated with anti-osteoporotic medication

Exclusion criteria

Exclusion criteria: -patients with a fracture after a traffic accident -patients with a pathological fracture -patients with fractures of hand, foot or scull -serious comorbidity or dementia -incapable of visiting the out patient clinic

Design outcomes

Primary

MeasureTime frame
I) is it possible to increase the proportion of patients adequately screened and categorized as to the presence of osteoporosis from current practice of 5-40% to at least 70%? II) in patients found to have osteoporosis, is it possible to: a) start treatment in nearly all applicable patients? b) maintain the proportion of patients still on anti-osteoporotic treatment after 1 year at 70% of those starting treatment?

Secondary

MeasureTime frame
III) are the data on subsequent fracture rates compatible with a reduction to 4%? IV) is the proportion of patients screened for osteoporosis with a DXA measurement significantly higher in the implementation group (with fracture nurse) than in the control group (without a fracture nurse; 'usual care')? V) is the proportion of patients still on anti-osteoporotic treatment after 1 year significantly higher in the implementation group than in the control group? VI) what are the costs associated with the implementation of an osteoporosis nurse and how do these costs compare to the health benefits obtained. VII) what are the practical barriers encountered in trying to achieve the above mentioned goals? VIII) what are the practical barriers in the implementation of an osteoporosis nurse, and how can these be overcome? concerning population 2 and 3: 1. a) what proportion of patients without vertebral fractures and with a T score of * -1 and >-2, has sustained a new clinical fracture one year after the initial fracture? b) what proportion of patients already being treated with anti-osteoporotic medication, has sustained a new clinical fracture one year after the initial fracture? 2. is the proportion of patients still on anti-osteoporotic treatment after 1 year significantly different in the implementation group than in the group of patients who are being treated by another clinician or general practitioner?

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)